Differential diagnosis of hypercalcitoninamia;Differentialdiagnose der hypercalcitoninamie

Tumor Diagnostik und Therapie

Volumn 19, Issue 3, 1998, Pages 60-63

  Sutter, T ^a   Machens, A ^a   Nguyen Thanh, P ^a   Holzhausen, H J ^a   Dralle, H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Hypercalcitoninemia; Medullary thyroid cancer; Neuroendocrine tumors

Indexed keywords

ADULT; CALCITONIN BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HUMAN; LARYNX CARCINOMA; NEUROENDOCRINE TUMOR; REVIEW; THYROID MEDULLARY CARCINOMA;

EID: 0031712936     PISSN: 0722219X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Becker KL, Nash D, Silva OL, et al. Increased serum and urinary calcitonin levels in patients with pulmonary disease. Chest 79 (1981) 211-216
2. Biddinger PW, Brennan MF, Rosen PP. Symptomatic C-cell hyperplasia associated with chronic lymphocytic thyroiditis. Amer. J. Surg. Pathol. 15 (1991) 599-604
3. Dralle H, Scheumann GFW, Kotzerke J, et al. Surgical managment of MEN 2. Rec. Res. Cancer. Res. 125 (1992) 167-195
4. Escalada J, Teruel JL, Pavon I, et al. Normal calcitonin response to pentagastrin stimulation in patients with chronic renal failure. Acta Endocrinologica 129 (1993) 39-41
5. Hansen M, Hansen HH, Tryding N. Small cell carcinoma of the lung: serum calcitonin and serum histaminase (diamine oxidase) at basal levels and stimulated by pentagastrin. Acta Med. Scand. 204 (1978) 257-261
6. Henry JF, Denizot A, Puccini M, et al. Diagnostic precoce des cancers medullaires sporadiques de la thyroide: interet du dosage systematique de la calcitonine. Presse Med. 25 (1996) 1583-1588
7. Milroy M, Rode J, Moß E. Laryngeal paragangliomas and neuroendocrine carcinomas. Histopathology 18 (1991) 201-209
8. Niccoli P, Brunet P, Roubicek C, et al. Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis. Eur. J. Endocrinol. 132 (1995) 75-81
9. Niccoli P, Conte-Devolx B, Lejeune PJ, et al. Les Hypercalcitoninemies en dehors des cancers medullaires de la thyroide. Ann. Endocrinol. Paris 57 (1996) 15-21
10. O'Neill WJ, Jordan MH, Lewis MS, et al. Serum calcitonin may be a marker for inhalation injury in burns. J. Burn. Care. Rehabil. 13 (1992) 605-616
11. Pearse AGE. Common cytochemical and ultrastructural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid ultimobranchial C cells and calcitonin. Proc. R. Soc. Lond. (Biol.) 170 (1968) 71-80
12. Rebollo M, Guerrero J. Posible utilidad de la calcitonin serica en pacientes septicos en riesgo de desarrolar SIRPA. Rev. Invest. Clin. 44 (1992) 575-578
13. Saint-Andre JP, Guyetant S. Hypercalcitoninemies non tumorales. Anatomie pathologique. Ann. Endocrinol. Paris 57 (1996) 23-26
14. Tisell LE, Dilley WG, Wells SA Jr. Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels. Surgery 119 (1996) 34-39
15. Vierhapper H, Raber W, Bieglmayer C, et al. Routine measurement of plasma calcitonin in nodular thyroid diseases. J. Clin. Endocrinol. Metab. 82 (1997) 1589-1593
16. Vilde F, Arkwright S, Paoli C, et al. Carcinome neuroendocrine larynge avec secretion de calcitonine: cancer primitif ou metastase d'un cancer medullaire de la thyroide? Ann. Pathol. 16 (1996) 104-107
17. Woodruff JM, Huvos AG, Erlandson RA, et al. Neuroendocrine carcinomas of the larynx. Am. J. Surg. Pathol. 9 (1985) 771-790